These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


726 related items for PubMed ID: 9828096

  • 1. The cyclin-dependent kinase inhibitors olomoucine and roscovitine arrest human fibroblasts in G1 phase by specific inhibition of CDK2 kinase activity.
    Alessi F, Quarta S, Savio M, Riva F, Rossi L, Stivala LA, Scovassi AI, Meijer L, Prosperi E.
    Exp Cell Res; 1998 Nov 25; 245(1):8-18. PubMed ID: 9828096
    [Abstract] [Full Text] [Related]

  • 2. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5.
    Meijer L, Borgne A, Mulner O, Chong JP, Blow JJ, Inagaki N, Inagaki M, Delcros JG, Moulinoux JP.
    Eur J Biochem; 1997 Jan 15; 243(1-2):527-36. PubMed ID: 9030781
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cyclin-dependent kinase inhibitors block proliferation of human gastric cancer cells.
    Iseki H, Ko TC, Xue XY, Seapan A, Hellmich MR, Townsend CM.
    Surgery; 1997 Aug 15; 122(2):187-94; discussion 194-5. PubMed ID: 9288122
    [Abstract] [Full Text] [Related]

  • 5. Potent inhibitors of cyclin-dependent kinase 2 induce nuclear accumulation of wild-type p53 and nucleolar fragmentation in human untransformed and tumor-derived cells.
    David-Pfeuty T.
    Oncogene; 1999 Dec 09; 18(52):7409-22. PubMed ID: 10602500
    [Abstract] [Full Text] [Related]

  • 6. Adenovirus-mediated E2F-1 gene transfer induces an apoptotic response in human gastric carcinoma cells that is enhanced by cyclin dependent kinase inhibitors.
    Atienza C, Elliott MJ, Dong YB, Yang HL, Stilwell A, Liu TJ, McMasters KM.
    Int J Mol Med; 2000 Jul 09; 6(1):55-63. PubMed ID: 10851267
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate.
    Liang YC, Lin-Shiau SY, Chen CF, Lin JK.
    J Cell Biochem; 1999 Oct 01; 75(1):1-12. PubMed ID: 10462699
    [Abstract] [Full Text] [Related]

  • 8. A novel strategy for inhibiting growth of human pancreatic cancer cells by blocking cyclin-dependent kinase activity.
    Iseki H, Ko TC, Xue XY, Seapan A, Townsend CM.
    J Gastrointest Surg; 1998 Oct 01; 2(1):36-43. PubMed ID: 9841966
    [Abstract] [Full Text] [Related]

  • 9. Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex.
    Yin MB, Guo B, Panadero A, Frank C, Wrzosek C, Slocum HK, Rustum YM.
    Exp Cell Res; 1999 Feb 25; 247(1):189-99. PubMed ID: 10047461
    [Abstract] [Full Text] [Related]

  • 10. CaMK-II inhibition reduces cyclin D1 levels and enhances the association of p27kip1 with Cdk2 to cause G1 arrest in NIH 3T3 cells.
    Morris TA, DeLorenzo RJ, Tombes RM.
    Exp Cell Res; 1998 May 01; 240(2):218-27. PubMed ID: 9596994
    [Abstract] [Full Text] [Related]

  • 11. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein.
    Reshetnikova G, Barkan R, Popov B, Nikolsky N, Chang LS.
    Exp Cell Res; 2000 Aug 25; 259(1):35-53. PubMed ID: 10942577
    [Abstract] [Full Text] [Related]

  • 12. G1 phase accumulation induced by UCN-01 is associated with dephosphorylation of Rb and CDK2 proteins as well as induction of CDK inhibitor p21/Cip1/WAF1/Sdi1 in p53-mutated human epidermoid carcinoma A431 cells.
    Akiyama T, Yoshida T, Tsujita T, Shimizu M, Mizukami T, Okabe M, Akinaga S.
    Cancer Res; 1997 Apr 15; 57(8):1495-501. PubMed ID: 9108451
    [Abstract] [Full Text] [Related]

  • 13. Downregulation of cyclin D1 alters cdk 4- and cdk 2-specific phosphorylation of retinoblastoma protein.
    Yu B, Lane ME, Pestell RG, Albanese C, Wadler S.
    Mol Cell Biol Res Commun; 2000 Jun 15; 3(6):352-9. PubMed ID: 11032757
    [Abstract] [Full Text] [Related]

  • 14. Cdc2 and Cdk2 kinase activated by transforming growth factor-beta1 trigger apoptosis through the phosphorylation of retinoblastoma protein in FaO hepatoma cells.
    Choi KS, Eom YW, Kang Y, Ha MJ, Rhee H, Yoon JW, Kim SJ.
    J Biol Chem; 1999 Nov 05; 274(45):31775-83. PubMed ID: 10542199
    [Abstract] [Full Text] [Related]

  • 15. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
    Sangfelt O, Erickson S, Castro J, Heiden T, Gustafsson A, Einhorn S, Grandér D.
    Oncogene; 1999 May 06; 18(18):2798-810. PubMed ID: 10362250
    [Abstract] [Full Text] [Related]

  • 16. c-Myc or cyclin D1 mimics estrogen effects on cyclin E-Cdk2 activation and cell cycle reentry.
    Prall OW, Rogan EM, Musgrove EA, Watts CK, Sutherland RL.
    Mol Cell Biol; 1998 Aug 06; 18(8):4499-508. PubMed ID: 9671459
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL, Buffolino P, Kopman C, Nathanson L.
    Exp Cell Res; 1995 Nov 06; 221(1):92-102. PubMed ID: 7589260
    [Abstract] [Full Text] [Related]

  • 18. Antiestrogen inhibition of cell cycle progression in breast cancer cells in associated with inhibition of cyclin-dependent kinase activity and decreased retinoblastoma protein phosphorylation.
    Watts CK, Brady A, Sarcevic B, deFazio A, Musgrove EA, Sutherland RL.
    Mol Endocrinol; 1995 Dec 06; 9(12):1804-13. PubMed ID: 8614416
    [Abstract] [Full Text] [Related]

  • 19. Interferon-alpha-induced G1 phase arrest through up-regulated expression of CDK inhibitors, p19Ink4D and p21Cip1 in mouse macrophages.
    Matsuoka M, Tani K, Asano S.
    Oncogene; 1998 Apr 23; 16(16):2075-86. PubMed ID: 9572488
    [Abstract] [Full Text] [Related]

  • 20. ERK pathway mediates the activation of Cdk2 in IGF-1-induced proliferation of human osteosarcoma MG-63 cells.
    Zhang W, Lee JC, Kumar S, Gowen M.
    J Bone Miner Res; 1999 Apr 23; 14(4):528-35. PubMed ID: 10234573
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 37.